Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
GJ McCaughan, S Gandolfi, JJ Moore… - British Journal of …, 2022 - Wiley Online Library
For patients with newly diagnosed multiple myeloma, survival outcomes continue to improve
significantly: however, nearly all patients will relapse following induction treatment …
significantly: however, nearly all patients will relapse following induction treatment …